DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zolinza (Vorinostat) - Adverse Event Reports - Serious Event - Weight Decreased

 



Index of reports > Cases resulting in a serious event (23) > Cases with Weight Decreased (5)

Below is the selection of adverse event reports related to Zolinza (Vorinostat) that includes cases resulting in a serious event where reactions include weight decreased.

Adverse event in 72 year old male receiving Zolinza (Vorinostat)

Reported by a physician from United States on 2007-10-03

Patient: 72 year old male

Adverse reactions / side effects: Weight Decreased, Nausea, Feeling Cold, Malaise, Fatigue, Dehydration, Anorexia, Malignant Melanoma, Dizziness

Suspect drug(s):
Zolinza
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2007-05-18
    End date: 2007-07-05

Zolinza
    Administration route: Oral
    Start date: 2007-07-05
    End date: 2007-07-21

Other drugs received by patient: Celebrex; Cyclobenzaprine Hydrochloride



Adverse event in 79 year old female receiving Zolinza (Vorinostat)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-10

Patient: 79 year old female, weighing 48.0 kg (105.6 pounds)

Adverse reactions / side effects: Weight Decreased, Chest Discomfort, Dyspnoea, Vomiting, Restlessness, Nausea, Muscular Weakness, Constipation, Discomfort, Drug Toxicity, Fatigue, Flank Pain, Anorexia, Oedema Peripheral, Cold Sweat, Heart Rate Abnormal

Suspect drug(s):
Zolinza
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2007-04-10
    End date: 2007-04-15

Zolinza
    Administration route: Oral
    Start date: 2007-04-17

Zolinza
    Administration route: Oral
    Start date: 2007-04-03

Other drugs received by patient: Boniva; Digoxin; Ranitidine; Metformin; Norvasc; Lipitor; Tricor; Hydroxyzine Hydrochloride; Synthroid; Clobetasol Propionate; Triamcinolone; Fluocinolone Acetonide; Vitamin E; Ascorbic Acid; Calcium (Unspecified); Docusate Sodium; Compazine



Adverse event in 69 year old female receiving Zolinza (Vorinostat)

Reported by a physician from United States on 2007-06-20

Patient: 69 year old female, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Weight Decreased, Anaemia, Mycosis Fungoides, Hepatitis B Positive, Transaminases Increased, Syncope, Anorexia, Dehydration, Hepatitis A Antibody Positive, Dizziness, Transient Ischaemic Attack, Hepatitis C Positive, Acute Prerenal Failure

Adverse event resulted in: hospitalization

Suspect drug(s):
Zolinza
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2007-02-02
    End date: 2007-03-01

Zolinza
    Administration route: Oral
    Start date: 2007-05-04
    End date: 2007-05-05

Zolinza
    Administration route: Oral
    Start date: 2007-03-02
    End date: 2007-04-20

Zolinza
    Administration route: Oral
    Start date: 2006-12-22



Adverse event in 69 year old female receiving Zolinza (Vorinostat)

Reported by a physician from United States on 2007-06-06

Patient: 69 year old female, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Weight Decreased, Anaemia, Mycosis Fungoides, Hepatitis B Positive, Transaminases Increased, Syncope, Anorexia, Dehydration, Hepatitis A Antibody Positive, Transient Ischaemic Attack, Hepatitis C Positive, Acute Prerenal Failure

Adverse event resulted in: hospitalization

Suspect drug(s):
Zolinza
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2007-02-02
    End date: 2007-03-01

Zolinza
    Administration route: Oral
    Start date: 2007-05-04
    End date: 2007-05-05

Zolinza
    Administration route: Oral
    Start date: 2007-03-02
    End date: 2007-04-20

Zolinza
    Administration route: Oral
    Start date: 2006-12-22



Adverse event in 78 year old female receiving Zolinza (Vorinostat)

Reported by a individual with unspecified qualification from United States on 2007-05-10

Patient: 78 year old female

Adverse reactions / side effects: Dysgeusia, Weight Decreased, Pruritus, Drug Ineffective, Nausea, RED Blood Cell Count Increased, Platelet Count Decreased

Suspect drug(s):
Zolinza
    Dosage: see image
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2006-11-30
    End date: 2007-01-19

Zolinza
    Dosage: see image
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2007-02-01

Kytril

Compazine

Other drugs received by patient: Levothyroxine Sodium

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009